Send to

Choose Destination
J Diabetes Res. 2017;2017:6726901. doi: 10.1155/2017/6726901. Epub 2017 Feb 28.

Forkhead Protein FoxO1 Acts as a Repressor to Inhibit Cell Differentiation in Human Fetal Pancreatic Progenitor Cells.

Author information

Shenzhen University Diabetes Institute, Shenzhen University, Shenzhen 518060, China.
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Shenzhen Hightide Biopharmaceutical Ltd., Shenzhen 518000, China.
Department of Aging Medicine, The Sixth Hospital of Shenzhen Municipality, Shenzhen 518060, China.


Our colleagues have reported previously that human pancreatic progenitor cells can readily differentiate into insulin-containing cells. Particularly, transplantation of these cell clusters upon in vitro induction for 3-4 w partially restores hyperglycemia in diabetic nude mice. In this study, we used human fetal pancreatic progenitor cells to identify the forkhead protein FoxO1 as the key regulator for cell differentiation. Thus, induction of human fetal pancreatic progenitor cells for 1 week led to increase of the pancreatic β cell markers such as Ngn3, but decrease of stem cell markers including Oct4, Nanog, and CK19. Of note, FoxO1 knockdown or FoxO1 inhibitor significantly upregulated Ngn3 and insulin as well as the markers such as Glut2, Kir6.2, SUR1, and VDCC, which are designated for mature β cells. On the contrary, overexpression of FoxO1 suppressed the induction and reduced expression of these β cell markers. Taken together, these results suggest that FoxO1 may act as a repressor to inhibit cell differentiation in human fetal pancreatic progenitor cells.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center